Device Trial Radar · NCT04862117
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
14
Actual
Start
Jul 28, 2018
Primary completion
Dec 8, 2026
Study completion Dec 8, 2026
Sponsor
- Lead sponsor
- SetPoint Medical CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 27, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Long-term extension of a multi-site, first-in-human study to assess safety and efficacy of an active implantable Vagus Nerve Stimulation (VNS) device in adult patients with active moderate-to-severe rheumatoid arthritis who have had an incomplete response or intolerability to at least two biologic and/or targeted synthetic DMARDs having at least two different mechanisms of action
Conditions
- Rheumatoid Arthritis
Interventions
SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway SystemDevice
Active Implantable Vagus Nerve Stimulation device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence rates of Adverse EventsTime frame: Enrollment through Month 36 (End of Study)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Arthritis & Rheumatic Disease Specialties
Aventura, Florida
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.